PT90802A - Processo para a preparacao de derivados de propanolamina e de composicoes farmaceuticas que os contem - Google Patents

Processo para a preparacao de derivados de propanolamina e de composicoes farmaceuticas que os contem

Info

Publication number
PT90802A
PT90802A PT90802A PT9080289A PT90802A PT 90802 A PT90802 A PT 90802A PT 90802 A PT90802 A PT 90802A PT 9080289 A PT9080289 A PT 9080289A PT 90802 A PT90802 A PT 90802A
Authority
PT
Portugal
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
propanolamine derivatives
propanolamine
Prior art date
Application number
PT90802A
Other languages
English (en)
Other versions
PT90802B (pt
Inventor
Frank Kienzle
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PT90802A publication Critical patent/PT90802A/pt
Publication of PT90802B publication Critical patent/PT90802B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/48Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
    • C07C215/52Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/60Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Gyroscopes (AREA)
  • Glass Compositions (AREA)
  • Steroid Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyridine Compounds (AREA)
PT90802A 1988-06-10 1989-06-09 Processo para a preparacao de derivados de propanolamina e de composicoes farmaceuticas que os contem PT90802B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH224588 1988-06-10

Publications (2)

Publication Number Publication Date
PT90802A true PT90802A (pt) 1989-12-29
PT90802B PT90802B (pt) 1994-11-30

Family

ID=4229254

Family Applications (1)

Application Number Title Priority Date Filing Date
PT90802A PT90802B (pt) 1988-06-10 1989-06-09 Processo para a preparacao de derivados de propanolamina e de composicoes farmaceuticas que os contem

Country Status (20)

Country Link
US (1) US5045567A (pt)
EP (1) EP0345591B1 (pt)
JP (1) JPH0236158A (pt)
KR (1) KR910000600A (pt)
AT (1) ATE87610T1 (pt)
AU (1) AU622907B2 (pt)
DE (1) DE58903919D1 (pt)
DK (1) DK284289A (pt)
ES (1) ES2053866T3 (pt)
FI (1) FI892341A (pt)
HU (1) HUT55344A (pt)
IE (1) IE891855L (pt)
IL (1) IL90528A0 (pt)
MC (1) MC2042A1 (pt)
NO (1) NO170011C (pt)
NZ (1) NZ229456A (pt)
PH (1) PH26237A (pt)
PT (1) PT90802B (pt)
YU (1) YU118389A (pt)
ZA (1) ZA894210B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5578638A (en) * 1993-11-05 1996-11-26 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists
US5563171A (en) * 1993-11-05 1996-10-08 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3-adrenergic agonists
ATE268758T1 (de) * 1997-04-04 2004-06-15 Aventis Pharma Gmbh Hypolipidämische propanolaminderivate
DE19845403B4 (de) * 1998-10-02 2005-02-10 Aventis Pharma Deutschland Gmbh Mit Gallensäuren verknüpfte Propanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
DE19845405C2 (de) * 1998-10-02 2000-07-13 Aventis Pharma Gmbh Arylsubstituierte Propanolaminderivate und deren Verwendung

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7112938A (pt) * 1970-09-30 1972-04-05
US3888829A (en) * 1971-06-25 1975-06-10 Sandoz Ag N,n'-bis(3-hydroxy-2-(3,4-dihydroxy-phenyl)-1-propyl)-aliphatic-diamines
CA1142954A (en) * 1978-07-03 1983-03-15 Jack Mills Phenethanolamines, compositions containing the same, and method for effecting weight control
DE3267406D1 (en) * 1981-07-11 1985-12-19 Beecham Group Plc Secondary phenyl ethanol amines and their pharmaceutical use
CA1258454A (en) * 1982-08-10 1989-08-15 Leo Alig Phenethanolamines
EP0118489A1 (en) * 1982-08-27 1984-09-19 Beecham Group Plc Secondary arylethanolamines
EP0139921B1 (en) * 1983-08-17 1987-03-25 Beecham Group Plc 2-phenylethylamine derivatives
EP0142102B1 (en) * 1983-11-04 1987-09-23 Beecham Group Plc Tertiary amines
CA1249992A (en) * 1983-11-10 1989-02-14 Marcel Muller Oxazolidines
FR2588556B1 (fr) * 1985-10-11 1988-01-08 Sanofi Sa Derives du naphtalene substitues par un groupement (omega-amino) alcanol a activite antimicrobienne, leur preparation et les compositions les contenant
CA1287061C (en) * 1986-06-27 1991-07-30 Roche Holding Ltd. Pyridine ethanolamine derivatives
DE3866984D1 (en) * 1987-07-21 1992-01-30 Hoffmann La Roche Phenoxypropanolamine.

Also Published As

Publication number Publication date
FI892341A0 (fi) 1989-05-16
KR910000600A (ko) 1991-01-29
PT90802B (pt) 1994-11-30
NO170011B (no) 1992-05-25
DE58903919D1 (en) 1993-05-06
IE891855L (en) 1989-12-10
US5045567A (en) 1991-09-03
ES2053866T3 (es) 1994-08-01
IL90528A0 (en) 1990-01-18
YU118389A (en) 1991-06-30
NZ229456A (en) 1992-02-25
DK284289A (da) 1989-12-11
NO892387L (no) 1989-12-11
HUT55344A (en) 1991-05-28
EP0345591A1 (de) 1989-12-13
FI892341A (fi) 1989-12-11
NO892387D0 (no) 1989-06-09
AU622907B2 (en) 1992-04-30
DK284289D0 (da) 1989-06-09
PH26237A (en) 1992-04-01
AU3602689A (en) 1989-12-14
NO170011C (no) 1992-09-02
MC2042A1 (fr) 1990-05-30
ZA894210B (en) 1990-03-28
JPH0236158A (ja) 1990-02-06
ATE87610T1 (de) 1993-04-15
EP0345591B1 (de) 1993-03-31

Similar Documents

Publication Publication Date Title
DK0539448T3 (da) Levnedsmiddelsammensætninger og farmaceutiske sammensætninger indeholdende kortkædede, monoumættede fedtsyrer og fremgangsmåde til anvendelse
PT85184A (en) Process for the preparation of pyridine ethanolamine derivatives and of pharmaceutical compositions containing the same
PT80828B (pt) Processo para a preparacao de composicoes farmaceuticas contendo uma mistura de, pelo menos, um derivado de xantina com acido o-acetilsalicilico ou os seus sais farmaceuticamente aceitaveis
PT87988A (pt) Processo para a preparacao de diazois e de composicoes farmaceuticas que os contem
ES2062239T3 (es) Diamidas de acidos pirimidin-4,6-dicarboxilicos, procedimiento para su preparacion, utilizacion de las mismas, asi como medicamentos a base de estos compuestos.
PT82987B (pt) Processo para a preparacao de novos de derivados de acidos carboxilicos bem como de composicoes farmaceuticas que os contem
PT72507A (en) Process for the preparation of 3,4,5-trihydroxypiperidine derivatives having effect upon the carbohydrates and lipids metabolism and application thereof for the preparation of pharmaceutical and/or veterinary compositions having effect upon the carbohydrates and lipids metabolism
FR2785807B1 (fr) Formulation de complement alimentaire, composition alimentaire la comprenant, ses utilisations
PT90802A (pt) Processo para a preparacao de derivados de propanolamina e de composicoes farmaceuticas que os contem
EP0667152A1 (de) Orale Verwendung von Calciumformiat zur Behandlung von Calciumdefizienz bei Tieren
PT91362A (pt) Processo para a preparacao de novos acidos 6-fluor-3,5-di-hidroxi-carboxilicos e seus derivados, e de composicoes farmaceuticas que os contem e de produtos intermediarios
ATE3033T1 (de) Derivate des 2-hydroxymethyl-3,4,5-trihydroxypiperidins, ihre herstellung und sie enthaltende arzneimittel.
ES2043062T3 (es) Procedimiento de preparacion de una composicion farmaceutica y/o dietetica.
BR8802816A (pt) Derivados do acido(2-ciano-9-oximinoacetil)-aminico,processo para sua preparacao,composicoes praguicidas,processos para combater pragas e para a preparacao de composicoes
DE3612232A1 (de) Verwendung von menschlichem urogastron zur foerderung der heilung von knochen und/oder sehnen
PT89350A (pt) Processo para a preparacao de uma combinacao sinergistica de inibidores de descarboxilase e de l-dopa e de composicoes farmaceuticas que a contem
BR9406629A (pt) Composições antiacidas liquidas
DE1692463A1 (de) Stimulans fuer das Wachstum und die Entwicklung von Tieren,von Gefluegel sowie Verfahren zur Herstellung desselben
IT8819546A0 (it) Composizione veterinaria sinergica e/o miscela preparata di mangime eprocedimento per la loro preparazione.
EP0386603A3 (de) Bisphenäthanolamine
ES508757A0 (es) "procedimiento para la preparacion de acidos antranilicos sustituidos con radicales basicos"
DE3866105D1 (de) Pirlimycin wachstumsteigerndes mittel fuer fleischproduzierende tiere.
DE2104345A1 (en) Tris-benzylideneaminoguanidines - for combatting coccidiosis in domestic animals
KR890001582A (ko) 향류머티스제
KR930022964A (ko) n-3 지방산 비율이 높은 닭고기 및 육계용 사료조성물

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19940518

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19951130